10x Genomics, Inc.
TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chā¦ read more
Healthcare
Health Information Services
6 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$18.79
Price-0.79%
-$0.15
1Y
Price
Market Cap
$2.400b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-11.8%
EBITDA Margin-9.8%
Net Profit Margin+23.5%
Free Cash Flow Margin-11.8%
EBITDA Margin-9.8%
Net Profit Margin+23.5%
Free Cash Flow MarginRevenue
$642.823m
+5.3%
1y CAGR+7.9%
3y CAGR+7.3%
5y CAGREarnings
-$43.544m
+76.2%
1y CAGR+17.0%
3y CAGR-33.5%
5y CAGREPS
-$0.35
+77.0%
1y CAGR+19.3%
3y CAGR-29.4%
5y CAGRBook Value
$796.326m
$1.041b
Assets$245.039m
Liabilities$157.737m
DebtDebt to Assets
15.2%
-12.6x
Debt to EBITDAFree Cash Flow
$130.115m
+2371.2%
1y CAGR+841.1%
3y CAGR+622.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company